Otitis media and its consequences: beyond the earache

The Lancet Infectious Diseases

Volumn 10, Issue 3, 2010, Pages 195-203

  Vergison, Anne ^a   Dagan, Ron ^b   Arguedas, Adriano ^c   Bonhoeffer, Jan ^d   Cohen, Robert ^e   DHooge, Ingeborg ^f   Hoberman, Alejandro ^g   Liese, Johannes ^h   Marchisio, Paola ⁱ   Palmu, Arto A ^j   Ray, G Thomas ^k   Sanders, Elisabeth AM ^l   Simões, Eric AF ^m   Uhari, Matti ⁿ   van Eldere, Johan ^o   Pelton, Stephen I ^p  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c Instituto de Atencion Pediatrica Costa Rica   (Costa Rica)

^d UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^e Créteil Hospital   (France)

^f GHENT UNIVERSITY HOSPITAL   (Belgium)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

ⁱ UNIVERSITY OF MILAN   (Italy)

^j NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^k DIVISION OF RESEARCH   (United States)

^l UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^m Children's Hospital Colorado   (United States)

ⁿ UNIVERSITY OF OULU   (Finland)

^o UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^p BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BACTERIAL VACCINE; CEPHALOSPORIN; PNEUMOCOCCUS VACCINE; VIRUS VACCINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL INFECTION; DEVELOPING COUNTRY; DIAGNOSTIC ACCURACY; DRUG TREATMENT FAILURE; GEOGRAPHIC DISTRIBUTION; HAEMOPHILUS INFLUENZAE; HUMAN; OTALGIA; OTITIS MEDIA; OTOSCOPY; PRACTICE GUIDELINE; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIAE; WORLD HEALTH ORGANIZATION;

EID: 76849096087     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70012-8     Document Type: Note

References (109)

1. Pelton SI, Schilder J, Liese J, Kvaerner K, Dean C, A, Arguedas. Perceived burden of disease and variation in the treatment of otitis media-result from a multinational survey. 13th International Congress of Infectious Diseases; Kuala Lumpur, Malaysia; June 19-22, 2008. Abstract 15.048.
2. Teele D.W., Klein J.O., and Rosner B. Epidemiology of otitis media during the first seven years of life in children in greater Boston: a prospective, cohort study. J Infect Dis 160 (1989) 83-94
3. Cripps A.W., Otczyk D.C., and Kyd J.M. Bacterial otitis media: a vaccine preventable disease?. Vaccine 23 (2005) 2304-2310
4. Casselbrant M. Epidemiology. In: Hamilton O.B., and Decker (Eds). Evidence-based otitis media (1999), PMPH-USA, Shelton, CT 117-136
5. Paradise J.L., Rockette H.E., Colborn D.K., et al. Otitis media in 2253 Pittsburgh-area infants: prevalence and risk factors during the first two years of life. Pediatrics 99 (1997) 318-333
6. Earnshaw S., Monnet D.L., Duncan B., O'Toole J., Ekdahl K., and Goossens H. European Antibiotic Awareness Day, 2008-the first Europe-wide public information campaign on prudent antibiotic use: methods and survey of activities in participating countries. Euro Surveill 14 (2009) 19280
7. Grijalva C.G., Nuorti J.P., and Griffin M.R. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 302 (2009) 758-766
8. Berman S. Otitis media in developing countries. Pediatrics 96 (1995) 126-131
9. Acuin J. Chronic suppurative otitis media: burden of illness and management options (2004), World Health Organization, Geneva. http://www.who.int/pbd/deafness/activities/hearing_care/otitis_media.pdf (accessed Jan 28, 2010).
10. Morris P.S., Leach A.J., Halpin S., et al. An overview of acute otitis media in Australian Aboriginal children living in remote communities. Vaccine 25 (2007) 2389-2393
11. Curns A.T., Holman R.C., Shay D.K., et al. Outpatient and hospital visits associated with otitis media among American Indian and Alaska native children younger than 5 years. Pediatrics 109 (2002) E41
12. Sanders S., Glasziou P.P., Del Mar C.B., and Rovers M.M. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev 1 (2010) CD000219.
13. Goossens H., Ferech M., Vander Stichele R., and Elseviers M. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005) 579-587
14. Razon Y., Ashkenazi S., Cohen A., et al. Effect of educational intervention on antibiotic prescription practices for upper respiratory infections in children: a multicentre study. J Antimicrob Chemother 56 (2005) 937-940
15. Woolley S.L., and Smith D.R. Acute otitis media in children-there are guidelines but are they followed?. J Laryngol Otol 119 (2005) 524-528
16. Vernacchio L., Vezina R.M., and Mitchell A.A. Management of acute otitis media by primary care physicians: trends since the release of the 2004 American Academy of Pediatrics/American Academy of Family Physicians clinical practice guideline. Pediatrics 120 (2007) 281-287
17. Arkins E.R., and Koehler J.M. Use of the observation option and compliance with guidelines in treatment of acute otitis media. Ann Pharmacother 42 (2008) 726-727
18. Akkerman A.E., Kuyvenhoven M.M., van der Wouden J.C., and Verheij T.J. Analysis of under- and overprescribing of antibiotics in acute otitis media in general practice. J Antimicrob Chemother 56 (2005) 569-574
19. Marchisio P., Mira E., Klersy C., et al. Medical education and attitudes about acute otitis media guidelines: a survey of Italian pediatricians and otolaryngologists. Pediatr Infect Dis J 28 (2009) 1-4
20. American Academy of Pediatrics Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics 113 (2004) 1451-1465
21. Appelman C.v., van de Lisdonk E.H., van Weert H.C.L.M., and Eizenga W.H. Guideline 'Acute Otitis Media' from the Dutch College of General Practitioners, first revision. Huisarts Wet 33 (1999) 242-245 (in Dutch).
22. Bain J., Townsley P., Boyle K., et al. Diagnosis and managment of childhood otitis media in primary care: guideline no 66 (2003), Scottish Intercollegiate Guidelines Network, Edinburgh
23. Friedman N.R., McCormick D.P., Pittman C., et al. Development of a practical tool for assessing the severity of acute otitis media. Pediatr Infect Dis J 25 (2006) 101-107
24. Pichichero M.E., and Casey J.R. Diagnostic inaccuracy and subject exclusions render placebo and observational studies of acute otitis media inconclusive. Pediatr Infect Dis J 27 (2008) 958-962
25. Rovers M.M., Glasziou P., Appelman C.L., et al. Antibiotics for acute otitis media: a meta-analysis with individual patient data. Lancet 368 (2006) 1429-1435
26. Schilder A.G., Lok W., and Rovers M.M. International perspectives on management of acute otitis media: a qualitative review. Int J Pediatr Otorhinolaryngol 68 (2004) 29-36
27. Jansen A.G., Sanders E.A., Schilder A.G., Hoes A.W., de Jong V.F., and Hak E. Primary care management of respiratory tract infections in Dutch preschool children. Scand J Prim Health Care 24 (2006) 231-236
28. Thompson P.L., Gilbert R.E., Long P.F., Saxena S., Sharland M., and Wong I.C. Effect of antibiotics for otitis media on mastoiditis in children: a retrospective cohort study using the United Kingdom general practice research database. Pediatrics 123 (2009) 424-430
29. Kontiokari T., Koivunen P., Niemela M., Pokka T., and Uhari M. Symptoms of acute otitis media. Pediatr Infect Dis J 17 (1998) 676-679
30. Hoberman A., and Paradise J.L. Acute otitis media: diagnosis and management in the year 2000. Pediatr Ann 29 (2000) 609-620
31. Pichichero M.E. Acute otitis media-part I: improving diagnostic accuracy. Am Fam Physician 61 (2000) 2051-2056
32. Pichichero M.E. Diagnostic accuracy, tympanocentesis training performance, and antibiotic selection by pediatric residents in management of otitis media. Pediatrics 110 (2002) 1064-1070
33. Steinbach W.J., Sectish T.C., Benjamin Jr. D.K., Chang K.W., and Messner A.H. Pediatric residents' clinical diagnostic accuracy of otitis media. Pediatrics 109 (2002) 993-998
34. Melegaro A., and Edmunds W.J. Cost-effectiveness analysis of pneumococcal conjugate vaccination in England and Wales. Vaccine 22 (2004) 4203-4214
35. Plasschaert A.I., Rovers M.M., Schilder A.G., Verheij T.J., and Hak E. Trends in doctor consultations, antibiotic prescription, and specialist referrals for otitis media in children: 1995-2003. Pediatrics 117 (2006) 1879-1886
36. Perez M.R., Victor P.R., Ruiz L.G., Castellano J.T., Tabares R.B., and Perez C.F. Acute otitis media in a pediatric primary care unit. An Pediatr (Barc) 61 (2004) 408-412 (in Spanish).
37. Garces-Sanchez M., Diez-Domingo J., de Labiada T.A., et al. Epidemiology and burden of acute otitis media in Valencia (Spain). An Pediatr (Barc) 60 (2004) 125-132 (in Spanish).
38. Prymula R., Peeters P., Chrobok V., et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 367 (2006) 740-748
39. Eskola J., Kilpi T., Palmu A., et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344 (2001) 403-409
40. Beutels P., Van Damme P., and Oosterhuis-Kafeja F. Effet et coûts de la vaccination des enfants Belges au moyen du vaccin conjugué anti-pneumococcique-report no 33B (2006), Centre fédéral d'expertise des soins de santé (KCE), Brussels
41. Adam D., and Fehnle K. Safety and effectiveness against respiratory tract infections for pneumococcal conjugate vaccine co-administered with routine vaccine combinations. Vaccine 26 (2008) 5944-5951
42. Dagan R., Schneider S., Givon-Lavi N., et al. Failure to achieve early bacterial eradication increases clinical failure rate in acute otitis media in young children. Pediatr Infect Dis J 27 (2008) 200-206
43. Leskinen K., and Jero J. Complications of acute otitis media in children in southern Finland. Int J Pediatr Otorhinolaryngol 68 (2004) 317-324
44. Van Zuijlen D.A., Schilder A.G., Van Balen F.A., and Hoes A.W. National differences in incidence of acute mastoiditis: relationship to prescribing patterns of antibiotics for acute otitis media?. Pediatr Infect Dis J 20 (2001) 140-144
45. Petersen I., Johnson A.M., Islam A., Duckworth G., Livermore D.M., and Hayward A.C. Protective effect of antibiotics against serious complications of common respiratory tract infections: retrospective cohort study with the UK General Practice Research Database. BMJ 335 (2007) 982
46. Shehab N., Patel P.R., Srinivasan A., and Budnitz D.S. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis 47 (2008) 735-743
47. Arason V.A., Kristinsson K.G., Sigurdsson J.A., Stefansdottir G., Molstad S., and Gudmundsson S. Do antimicrobials increase the carriage rate of penicillin resistant pneumococci in children? Cross sectional prevalence study. BMJ 313 (1996) 387-391
48. Yagupsky P., Porat N., Fraser D., et al. Acquisition, carriage, and transmission of pneumococci with decreased antibiotic susceptibility in young children attending a day care facility in southern Israel. J Infect Dis 177 (1998) 1003-1012
49. Catry B, Hendrickx E, Preal R, Mertens R. Risk factors for methicillin-resistant Staphylococcus aureus. 19th European Congress of Clinical Microbiology and Infectious Diseases; Helsinki, Finland; May 16-19, 2009.
50. Greenberg D., Givon-Lavi N., Sharf A.Z., Vardy D., and Dagan R. The association between antibiotic use in the community and nasopharyngeal carriage of antibiotic-resistant Streptococcus pneumoniae in Bedouin children. Pediatr Infect Dis J 27 (2008) 776-782
51. Vanderkooi O.G., Low D.E., Green K., Powis J.E., and McGeer A. Predicting antimicrobial resistance in invasive pneumococcal infections. Clin Infect Dis 40 (2005) 1288-1297
52. Davis K.A., Stewart J.J., Crouch H.K., Florez C.E., and Hospenthal D.R. Methicillin-resistant Staphylococcus aureus (MRSA) nares colonization at hospital admission and its effect on subsequent MRSA infection. Clin Infect Dis 39 (2004) 776-782
53. Barkai G., Greenberg D., Givon-Lavi N., Dreifuss E., Vardy D., and Dagan R. Community prescribing and resistant Streptococcus pneumoniae. Emerg Infect Dis 11 (2005) 829-837
54. Dagan R., Barkai G., Givon-Lavi N., et al. Seasonality of antibiotic-resistant Streptococcus pneumoniae that causes acute otitis media: a clue for an antibiotic-restriction policy?. J Infect Dis 197 (2008) 1094-1102
55. Pichichero M.E., and Casey J.R. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA 298 (2007) 1772-1778
56. Dabernat H., Seguy M., Faucon G., and Delmas C. Epidemiology of Haemophilus influenzae strains collected in 2004 in France and in vitro assessment of their susceptibility to antibiotics. Med Mal Infect 37 (2007) 320-324 (in French).
57. Garcia-Cobos S., Campos J., Lazaro E., et al. Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime. Antimicrob Agents Chemother 51 (2007) 2564-2573
58. Hotomi M., Sakai K.F., Billal D.S., Shimada J., Suzumoto M., and Yamanaka N. Antimicrobial resistance in Haemophilus influenzae isolated from the nasopharynx among Japanese children with acute otitis media. Acta Otolaryngol 126 (2006) 130-137
59. Dagan R., and Klugman K.P. Impact of conjugate pneumococcal vaccines on antibiotic resistance. Lancet Infect Dis 8 (2008) 785-795
60. Cohen R., Levy C., de La Rocque F., et al. Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media. Pediatr Infect Dis J 25 (2006) 1001-1007
61. Chonmaitree T., Revai K., Grady J.J., et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis 46 (2008) 815-823
62. Brook I. The role of bacterial interference in otitis, sinusitis and tonsillitis. Otolaryngol Head Neck Surg 133 (2005) 139-146
63. Rovers M., Haggard M., Gannon M., Koeppen-Schomerus G., and Plomin R. Heritability of symptom domains in otitis media: a longitudinal study of 1373 twin pairs. Am J Epidemiol 155 (2002) 958-964
64. Uhari M., Mantysaari K., and Niemela M. A meta-analytic review of the risk factors for acute otitis media. Clin Infect Dis 22 (1996) 1079-1083
65. Niemela M., Pihakari O., Pokka T., and Uhari M. Pacifier as a risk factor for acute otitis media: a randomized, controlled trial of parental counseling. Pediatrics 106 (2000) 483-488
66. Roos K., Hakansson E.G., and Holm S. Effect of recolonisation with "interfering" α streptococci on recurrences of acute and secretory otitis media in children: randomised placebo controlled trial. BMJ 322 (2001) 210-212
67. Uhari M., and Mottonen M. An open randomized controlled trial of infection prevention in child day-care centers. Pediatr Infect Dis J 18 (1999) 672-677
68. Uhari M., Kontiokari T., Koskela M., and Niemela M. Xylitol chewing gum in prevention of acute otitis media: double blind randomised trial. BMJ 313 (1996) 1180-1184
69. Uhari M., Kontiokari T., and Niemela M. A novel use of xylitol sugar in preventing acute otitis media. Pediatrics 102 (1998) 879-884
70. Hautalahti O., Renko M., Tapiainen T., Kontiokari T., Pokka T., and Uhari M. Failure of xylitol given three times a day for preventing acute otitis media. Pediatr Infect Dis J 26 (2007) 423-427
71. Belmaker I., Dukhan L., Yosef Y., Leventhal A., and Dagan R. Elimination of hepatitis a infection outbreaks in day care and school settings in southern Israel after introduction of the national universal toddler hepatitis a immunization program. Pediatr Infect Dis J 26 (2007) 36-40
72. Zanetti A.R., Van Damme P., and Shouval D. The global impact of vaccination against hepatitis B: a historical overview. Vaccine 26 (2008) 6266-6273
73. Parashar U.D., and Glass R.I. Rotavirus vaccines-early success, remaining questions. N Engl J Med 360 (2009) 1063-1065
74. Vergison A. Microbiology of otitis media: a moving target. Vaccine 26 suppl 7 (2008) G5-G10
75. Segal N., Givon-Lavi N., Leibovitz E., Yagupsky P., Leiberman A., and Dagan R. Acute otitis media caused by Streptococcus pyogenes in children. Clin Infect Dis 41 (2005) 35-41
76. Manzoli L., Schioppa F., Boccia A., and Villari P. The efficacy of influenza vaccine for healthy children: a meta-analysis evaluating potential sources of variation in efficacy estimates including study quality. Pediatr Infect Dis J 26 (2007) 97-106
77. Jefferson T., Rivetti A., Harnden A., Di Pietrantonj C., and Demicheli V. Vaccines for preventing influenza in healthy children. Cochrane Database Syst Rev 2 (2008) CD004879
78. Hoberman A., Greenberg D.P., Paradise J.L., et al. Effectiveness of inactivated influenza vaccine in preventing acute otitis media in young children: a randomized controlled trial. JAMA 290 (2003) 1608-1616
79. Black S., Shinefield H., Fireman B., et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 19 (2000) 187-195
80. Kilpi T., Ahman H., Jokinen J., et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 37 (2003) 1155-1164
81. Dagan R., Sikuler-Cohen M., Zamir O., Janco J., Givon-Lavi N., and Fraser D. Effect of a conjugate pneumococcal vaccine on the occurrence of respiratory infections and antibiotic use in day-care center attendees. Pediatr Infect Dis J 20 (2001) 951-958
82. Palmu A.A., Verho J., Jokinen J., Karma P., and Kilpi T.M. The seven-valent pneumococcal conjugate vaccine reduces tympanostomy tube placement in children. Pediatr Infect Dis J 23 (2004) 732-738
83. Fireman B., Black S.B., Shinefield H.R., Lee J., Lewis E., and Ray P. Impact of the pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J 22 (2003) 10-16
84. Grijalva C.G., Poehling K.A., Nuorti J.P., et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics 118 (2006) 865-873
85. Poehling K.A., Szilagyi P.G., Grijalva C.G., et al. Reduction of frequent otitis media and pressure-equalizing tube insertions in children after introduction of pneumococcal conjugate vaccine. Pediatrics 119 (2007) 707-715
86. Zhou F., Shefer A., Kong Y., and Nuorti J.P. Trends in acute otitis media-related health care utilization by privately insured young children in the United States, 1997-2004. Pediatrics 121 (2008) 253-260
87. Wals P.D., Carbon M., Sevin E., Deceuninck G., and Ouakki M. Reduced physician claims for otitis media after implementation of pneumococcal conjugate vaccine program in the province of quebec, Canada. Pediatr Infect Dis J 28 (2009) e271-e275
88. Veenhoven R., Bogaert D., Uiterwaal C., et al. Effect of conjugate pneumococcal vaccine followed by polysaccharide pneumococcal vaccine on recurrent acute otitis media: a randomised study. Lancet 361 (2003) 2189-2195
89. van Kempen M.J., Vermeiren J.S., Vaneechoutte M., et al. Pneumococcal conjugate vaccination in children with recurrent acute otitis media: a therapeutic alternative?. Int J Pediatr Otorhinolaryngol 70 (2006) 275-285
90. Casey J.R., and Pichichero M.E. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J 23 (2004) 824-828
91. Block S.L., Hedrick J., Harrison C.J., et al. Community-wide vaccination with the heptavalent pneumococcal conjugate significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J 23 (2004) 829-833
92. Pichichero M.E., Casey J.R., Hoberman A., and Schwartz R. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006. Clin Pediatr (Phila) 47 (2008) 901-906
93. Hausdorff W.P., Yothers G., Dagan R., et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 21 (2002) 1008-1016
94. Porat N., Soley C., Marengolciene M.M., et al. An international serotype 3 clone causing pediatric noninvasive infections in Israel, Costa Rica, and Lithuania. Pediatr Infect Dis J 27 (2008) 709-712
95. Ongkasuwan J., Valdez T.A., Hulten K.G., Mason Jr. E.O., and Kaplan S.L. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics 122 (2008) 34-39
96. Mahjoub-Messai F., Doit C., Mariani-Kurkdjian P., Francois M., and Bingen E. Epidemiology of acute otitis media caused by Streptococcus pneumoniae: emergence of serotype 19A. Arch Pediatr 15 (2008) 1713-1716 (in French).
97. Dagan R., Givon-Lavi N., Leibovitz E., Greenberg D., and Porat N. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J Infect Dis 199 (2009) 776-785
98. O'Brien M., Prosser L.A., Paradise J.L., et al. New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics 123 (2009) 1452-1463
99. Pemba L., Charalambous S., von Gottberg A., et al. Impact of cotrimoxazole on non-susceptibility to antibiotics in Streptococcus pneumoniae carriage isolates among HIV-infected mineworkers in South Africa. J Infect 56 (2008) 171-178
100. Cotton M.F., Wasserman E., Smit J., Whitelaw A., and Zar H.J. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa. BMC Infect Dis 8 (2008) 40
101. Wolter N., von Gottberg A., du Plessis M., de Gouveia L., and Klugman K.P. Molecular basis and clonal nature of increasing pneumococcal macrolide resistance in South Africa, 2000-2005. Int J Antimicrob Agents 32 (2008) 62-67
102. Rutka J., and Lekagul S. No therapy: use, abuse, efficacy, and morbidity-the European versus the third-world experience. J Otolaryngol 27 suppl 2 (1998) 43-48
103. Luby S.P., Agboatwalla M., Feikin D.R., et al. Effect of handwashing on child health: a randomised controlled trial. Lancet 366 (2005) 225-233
104. Hill P.C., Cheung Y.B., Akisanya A., et al. Nasopharyngeal carriage of Streptococcus pneumoniae in Gambian infants: a longitudinal study. Clin Infect Dis 46 (2008) 807-814
105. Cutts F.T., Zaman S.M., Enwere G., et al. Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial. Lancet 365 (2005) 1139-1146
106. Klugman K.P., Madhi S.A., Huebner R.E., Kohberger R., Mbelle N., and Pierce N. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. N Engl J Med 349 (2003) 1341-1348
107. Mbelle N., Huebner R.E., Wasas A.D., Kimura A., Chang I., and Klugman K.P. Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 180 (1999) 1171-1176
108. Lucero M.G., Nohynek H., Williams G., et al. Efficacy of an 11-valent pneumococcal conjugate vaccine against radiologically confirmed pneumonia among children less than 2 years of age in the Philippines: a randomized, double-blind, placebo-controlled trial. Pediatr Infect Dis J 28 (2009) 455-462
109. Mackenzie G.A., Carapetis J.R., Leach A.J., and Morris P.S. Pneumococcal vaccination and otitis media in Australian Aboriginal infants: comparison of two birth cohorts before and after introduction of vaccination. BMC Pediatr 9 (2009) 14